Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMID 15455214)

Published in J Neural Transm (Vienna) on September 30, 2004

Authors

E Grünblatt1, S Mandel, J Jacob-Hirsch, S Zeligson, N Amariglo, G Rechavi, J Li, R Ravid, W Roggendorf, P Riederer, M B H Youdim

Author Affiliations

1: Institute of Clinical Neurochemistry and National Parkinson Foundation Centre of Excellence Laboratories, Clinic and Policlinic for Psychiatry and Psychotherapy, University of Würzburg, Germany.

Articles citing this

Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet (2008) 5.04

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48

Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet (2011) 2.12

Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci (2010) 1.96

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain (2008) 1.92

Transcriptional signatures in Huntington's disease. Prog Neurobiol (2007) 1.86

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics (2006) 1.79

The genetics of Parkinson disease. J Geriatr Psychiatry Neurol (2010) 1.69

Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol (2008) 1.62

The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res (2008) 1.54

Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis (2007) 1.53

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol (2006) 1.44

Retracted Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson's disease. BMC Neurol (2013) 1.41

Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32

A cross-study transcriptional analysis of Parkinson's disease. PLoS One (2009) 1.19

Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci (2014) 1.15

A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener (2012) 1.13

Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One (2013) 1.12

Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08

Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol (2012) 1.07

SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One (2010) 1.07

Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci (2008) 1.06

Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm (Vienna) (2011) 1.04

Replication of GWAS associations for GAK and MAPT in Parkinson's disease. Ann Hum Genet (2010) 1.03

The significance of neuronal lateralisation in Parkinson's disease. J Neural Transm (Vienna) (2012) 1.03

Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis. Front Mol Neurosci (2014) 1.03

Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother (2010) 1.01

Neuronal gene expression correlates of Parkinson's disease with dementia. Mov Disord (2008) 0.96

Microarrays in Parkinson's disease: a systematic approach. NeuroRx (2006) 0.96

Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system. Brain Res (2011) 0.94

Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun (2014) 0.93

Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease. J Neural Transm (Vienna) (2010) 0.92

Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo. Neurobiol Dis (2008) 0.92

Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Hum Mol Genet (2011) 0.91

Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Neurochem Int (2007) 0.90

Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet (2011) 0.90

Mitochondrial Dysfunction in Parkinson's Disease. Exp Neurobiol (2015) 0.88

Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia. J Neurosci (2014) 0.87

Overexpression of alpha-synuclein down-regulates BDNF expression. Cell Mol Neurobiol (2010) 0.87

Are heat shock proteins therapeutic target for Parkinson's disease? Int J Biol Sci (2006) 0.86

Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease. Neurotherapeutics (2009) 0.86

Current status and future directions of gene expression profiling in Parkinson's disease. Neurobiol Dis (2010) 0.86

A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A. J Biol Chem (2009) 0.86

Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study. Parkinsons Dis (2012) 0.86

Gene expression in the Parkinson's disease brain. Brain Res Bull (2011) 0.85

Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease. Environ Res (2013) 0.85

CROPPER: a metagene creator resource for cross-platform and cross-species compendium studies. BMC Bioinformatics (2006) 0.84

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein. Front Behav Neurosci (2015) 0.83

Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization. BMC Med Genomics (2016) 0.83

Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biol (2013) 0.83

Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J Neural Transm (Vienna) (2014) 0.82

Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons. J Physiol (2006) 0.82

GWAS-linked GAK locus in Parkinson's disease in Han Chinese and meta-analysis. Hum Genet (2011) 0.81

Genetic variations of GAK in two Chinese Parkinson's disease populations: a case-control study. PLoS One (2013) 0.81

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease. Mol Neurodegener (2011) 0.81

Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease. Biomed Res Int (2014) 0.80

Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis. PLoS One (2015) 0.79

Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. J Neural Transm (Vienna) (2006) 0.79

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases. Front Neurosci (2016) 0.78

Global stress response in a prokaryotic model of DJ-1-associated Parkinsonism. J Bacteriol (2013) 0.77

CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations. J Neural Transm (Vienna) (2015) 0.77

Cortical-striatal gene expression in neonatal hippocampal lesion (NVHL)-amplified cocaine sensitization. Genes Brain Behav (2013) 0.77

Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. J Neural Transm (Vienna) (2014) 0.77

The coregulator Alien. Nucl Recept Signal (2007) 0.77

Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors. European J Med Plants (2016) 0.77

Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death. J Neural Transm (Vienna) (2011) 0.76

Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila. J Neural Transm (Vienna) (2008) 0.76

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease. PLoS One (2015) 0.76

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats. J Neural Transm (Vienna) (2010) 0.76

Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity. Dis Model Mech (2016) 0.76

Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease. Parkinsons Dis (2015) 0.75

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Sci Rep (2017) 0.75

Finding diamonds in the rubble. Exp Neurol (2007) 0.75

Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues. J Clin Neurol (2005) 0.75

Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm). Sci Rep (2016) 0.75

Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment. Exp Neurobiol (2014) 0.75

Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression. PLoS One (2016) 0.75

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease. Neural Regen Res (2017) 0.75

Articles by these authors

(truncated to the top 100)

The sequence of the human genome. Science (2001) 101.55

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02

Comparative genomics of the eukaryotes. Science (2000) 26.62

Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast (1998) 23.00

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23

Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol (1990) 7.85

Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol (1998) 7.76

Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A. Nature (1990) 7.32

Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity (2001) 6.56

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol (1996) 6.43

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67

Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A (1997) 5.32

Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 5.22

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol (1995) 5.01

Crystal structures of two Sm protein complexes and their implications for the assembly of the spliceosomal snRNPs. Cell (1999) 4.57

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell (2000) 4.53

Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci U S A (1998) 4.35

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res (1997) 4.32

Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. EMBO J (2001) 4.23

A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell (1998) 4.21

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother (2011) 4.21

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21

Dominance is the major genetic basis of heterosis in rice as revealed by QTL analysis using molecular markers. Genetics (1995) 4.18

Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science (1997) 4.03

Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest (1997) 4.00

Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol (2003) 3.93

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther (2003) 3.85

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84

Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med (2001) 3.80

Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology (1998) 3.79

Brassinosteroid-insensitive-1 is a ubiquitously expressed leucine-rich repeat receptor serine/threonine kinase. Plant Physiol (2000) 3.73

Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science (1995) 3.62

Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60

Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem (2001) 3.60

Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology (2005) 3.44

LifeLines: using visualization to enhance navigation and analysis of patient records. Proc AMIA Symp (1998) 3.35

Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. Aliment Pharmacol Ther (2014) 3.32

DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28

Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27

Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron (2001) 3.20

Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res (1997) 3.17

Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med (1998) 3.13

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem (2001) 3.13

Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol (1991) 3.09

Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol Med (2010) 3.08

Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1. Science (2000) 3.07

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res (1996) 3.03

Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr (2000) 3.02

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00

The Arabidopsis deetiolated2 mutant is blocked early in brassinosteroid biosynthesis. Plant Cell (1997) 3.00

Artificial 'spin ice' in a geometrically frustrated lattice of nanoscale ferromagnetic islands. Nature (2006) 2.96

Positioning of the mitotic spindle by a cortical-microtubule capture mechanism. Science (2000) 2.92

Identification of trait-improving quantitative trait loci alleles from a wild rice relative, Oryza rufipogon. Genetics (1998) 2.91

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91

The completeness, validity, and timeliness of AIDS surveillance data. Ann Epidemiol (2001) 2.89

The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem (2001) 2.89

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci U S A (2000) 2.83

Lagging strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen. J Biol Chem (1995) 2.80

Induction of meiosis in Saccharomyces cerevisiae depends on conversion of the transcriptional represssor Ume6 to a positive regulator by its regulated association with the transcriptional activator Ime1. Mol Cell Biol (1996) 2.79

The effects of poverty on child health and development. Annu Rev Public Health (1997) 2.78

16S rRNA gene-based detection of tetrachloroethene-dechlorinating Desulfuromonas and Dehalococcoides species. Appl Environ Microbiol (2000) 2.75

NMR structure of the bacteriophage lambda N peptide/boxB RNA complex: recognition of a GNRA fold by an arginine-rich motif. Cell (1998) 2.73

Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation (2001) 2.71

Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science (1996) 2.71

High-performance high-TC superconducting wires. Science (2006) 2.69

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61

Interaction of the sigma factor and the nusA gene protein of E. coli with RNA polymerase in the initiation-termination cycle of transcription. Cell (1981) 2.57

The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr Biol (1998) 2.57

Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum (2006) 2.57

SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol (2001) 2.56

Drought- and salt-tolerant plants result from overexpression of the AVP1 H+-pump. Proc Natl Acad Sci U S A (2001) 2.50

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50

Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol (1997) 2.49

Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47

High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum (2002) 2.45

Adolescents' attitudes to general practice in north London. Br J Gen Pract (1997) 2.45

Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 2.45

Molecular evolution and mosaic structure of alpha, beta, and gamma intimins of pathogenic Escherichia coli. Mol Biol Evol (1999) 2.44

The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature (1995) 2.44

The receptor binding site for the methyltransferase of bacterial chemotaxis is distinct from the sites of methylation. Biochemistry (1996) 2.44

Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science (1999) 2.43

Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res (1994) 2.40

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med (1997) 2.37

Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits. J Mol Biol (2002) 2.37

A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol (2004) 2.36

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene (2011) 2.36

Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35

A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol (2001) 2.33

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33

Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J (1994) 2.32

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol (1997) 2.28

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett (1994) 2.27